In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing bla KPC or bla NDM .

Junyang KuaiYawei ZhangBinghuai LuHongbin ChenYulin ZhangHenan LiYuanyuan WangQi WangHui WangXiaojuan Wang

Published in: Infection and drug resistance (2023)

Ceftazidime-avibactam plus aztreonam or meropenem could be an effective strategy for treating CRE infections, particularly those with high-level resistance to carbapenems and/or ceftazidime-avibactam.

Keyphrases

klebsiella pneumoniae
gram negative
multidrug resistant
escherichia coli
cancer therapy
drug delivery